U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06850363) titled 'ExaStim Upper Limb Home Use Clinical Validation Study' on Feb. 04.
Brief Summary: This is a multi-center, observational, single-arm, 6-week home study to evaluate the safety and efficacy of transcutaneous spinal cord stimulation via the ExaStim system for 4 consecutive weeks used in the home setting for individuals with traumatic spinal cord injury. The study consists of a baseline evaluation and 1-week training period (Week 0), a 4-week stimulation period (Weeks 1-4), and a follow-up visit (Week 5), for a total expected duration of participation for each subject of six weeks.
Study Start Date: March 04
Study Type: INTERVENTIONAL...